{"id":"W4288061296","doi":"10.1200/jco.2022.40.17_suppl.lba5004","title":"Updated overall survival outcomes in ENZAMET (ANZUP 1304), an international, cooperative group trial of enzalutamide in metastatic hormone-sensitive prostate cancer (mHSPC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Alberta; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Medicine; Enzalutamide; Docetaxel; Hazard ratio; Oncology; Internal medicine; Prostate cancer; Cohort; Cancer; Confidence interval; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005470246,0.0001792777,0.002029894,0.0004714393,0.00003551169,0.00001094969,0.0002480662,0.0001149041,0.0002857575],"category_scores_gemma":[0.001926034,0.0001272569,0.000306073,0.0003418912,0.0002428708,0.0002893296,0.0001493344,0.001504308,0.000001922874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000858537,"about_ca_system_score_gemma":0.00249602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007136352,"about_ca_topic_score_gemma":0.0008451249,"domain_scores_codex":[0.9938629,0.002170844,0.002559719,0.0002849662,0.0008096955,0.0003118638],"domain_scores_gemma":[0.9958895,0.001883772,0.001324962,0.0001684528,0.0005054722,0.0002278227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6660796,0.01614205,0.2794034,0.00002817912,0.002291909,0.005953983,0.003328005,0.001500376,0.001852928,0.0003735784,0.0009400756,0.02210589],"study_design_scores_gemma":[0.3284796,0.05773552,0.5973358,0.00007976646,0.0003541992,0.00009131553,0.002891002,0.0008352298,0.0002603614,0.0005469908,0.01115854,0.000231713],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905764,0.0003625992,0.000007038684,0.006051651,0.001614932,0.0008618041,0.0001350717,0.00000502934,0.0003854427],"genre_scores_gemma":[0.9953574,0.002386999,0.0005109967,0.0008098576,0.0002364319,0.00006881933,0.00006910329,0.0000214751,0.0005389028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3376001,"threshold_uncertainty_score":0.6535553,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1627605620197889,"score_gpt":0.515166324359394,"score_spread":0.3524057623396051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}